- Home
- ALT vs GRVY Comparison
ALT vs GRVY Comparison
Compare ALT & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | GRVY |
|---|---|---|
| Founded | 1997 | 2000 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 399.1M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | ALT | GRVY |
|---|---|---|
| Price | $3.61 | $56.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.33 | N/A |
| AVG Volume (30 Days) | ★ 4.8M | 17.3K |
| Earning Date | 11-06-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 8.02 |
| Revenue | $20,000.00 | ★ $399,496,744.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.15 |
| Revenue Growth | N/A | ★ 12.13 |
| 52 Week Low | $2.90 | $53.12 |
| 52 Week High | $7.83 | $70.00 |
Technical Indicators
Market Signals| Indicator | ALT | GRVY |
|---|---|---|
| Relative Strength Index (RSI) | 31.65 | 48.13 |
| Support Level | $3.83 | $55.80 |
| Resistance Level | $5.37 | $58.00 |
| Average True Range (ATR) | 0.33 | 1.40 |
| MACD | -0.19 | 0.15 |
| Stochastic Oscillator | 0.82 | 58.93 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.